Exogenous application of transforming growth factors-␤ (TGF␤) family proteins, including glial cell line-derived neurotrophic factor (GDNF), neurturin, activin, and bone morphogenetic proteins, has been shown to protect neurons in many models of neurological disorders. Finding a tissue source containing a variety of these proteins may promote optimal beneficial effects for treatment of neurodegenerative diseases. Because fetal kidneys express many TGF␤ trophic factors, we transplanted these tissues directly into the substantia nigra after a unilateral 6-hydroxydopamine lesion. We found that animals that received fetal kidney tissue grafts exhibited (1) significantly reduced hemiparkinsonian asymmetrical behaviors, (2) a near normal tyrosine hydroxylase immunoreactivity in the lesioned nigra and striatum, (3) a preservation of K ؉ -induced dopamine release in the lesioned striatum, and (4) high levels of GDNF protein within the grafts. In contrast, lesioned animals that received grafts of adult kidney tissues displayed significant behavioral deficits, dopaminergic depletion, reduced K ؉ -mediated striatal dopamine release, and low levels of GDNF protein within the grafts. The present study suggests that fetal kidney tissue grafts can protect the nigrostriatal dopaminergic system against a neurotoxin-induced parkinsonism, possibly through the synergistic release of GDNF and several other neurotrophic factors.
INTRODUCTION
Parkinson's disease (PD) afflicts more than 500,000 people in the United States and is characterized by extensive loss of dopamine neurons in the substantia nigra pars compacta and their terminals in the striatum (Hornykiewicz, 1973; Calne et al., 1984) . While the etiology of idiopathic PD is not known, several predisposing factors for the dopaminergic depletion associated with the disease have been suggested, including programmed cell death, viral infection, and environmental toxins. Many laboratories have been investigating mechanisms of, and possible treatments for, PD using animal models. The unilateral 6-hydroxydopamine (6-OHDA) lesioned rat is considered a standard model of PD (Ungerstedt and Arbuthnott, 1970; Ungerstedt, 1971) . Intracranial infusion of 6-OHDA reproduces neurochemical deficits seen in PD and pronounced behavioral asymmetries are manifested by unilaterally lesioned animals, including hemispatial neglect and pharmacologically induced rotational behavior (Marshall and Ungerstedt, 1977; Bracha et al., 1987) . The motor asymmetry can be detected either in a drug or drug-free state, and the
